D istinguishing malignant from benign soft-tissue tumors presents an important diagnostic dilemma. Several radiographic modalities are useful for initial investigation, including magnetic resonance imaging (MRI), which produces detailed images of soft-tissue abnormalities relative to adjacent anatomy, without the use of ionizing radiation. 1, 2 However, the ability of MRI to differentiate benign from malignant soft-tissue tumors is controversial. [3] [4] [5] [6] MRI could demonstrate some biologic characteristics of soft-tissue tumors, such as myxoid or fibrous tumors, better than the tumor activity or viability. Computed tomography (CT) and ultrasound are also available to demonstrate anatomic location of soft-tissue tumors. However, the quality and resolution of these imaging are not adequate enough to distinguish malignant from benign soft-tissue tumors.
Thallium-201 (201-Tl) scintigraphy is a functional scan that has been traditionally used as a measurement of myocardial perfusion and has also been investigated in tumors. 7 Although 201-Tl scintigraphy is reported to be useful for imaging and differentiating between malignant lesions and benign lesions, these studies were composed of small patient numbers and therefore failed to achieve statistical significance. 8 -12 In this study, we investigated 201-Tl scintigraphy as an indicator of malignancy in 193 soft-tissue tumors. We confirmed our findings by histologic examination of tumor biopsies, and report the sensitivity and specificity of 201-Tl scintigraphy to differentiate between malignant and benign soft-tissue tumors.
PATIENTS AND METHODS

Patient Demographics and Histopathologic Diagnosis
Between April 1995 and December 2005, 192 patients (98 male, 94 female) with soft-tissue tumors who presented to our clinic underwent 201-Tl scintigraphy before treatment. Before investigation of 201-Tl scintigraphy, all patients underwent MRI, and some of those also underwent CT for imaging assessment. Patient age ranged from 2 to 82 (mean, 49.6) years. Lesions were located primarily on the lower extremity (n ϭ 117), followed by the upper extremity (n ϭ 54) and trunk (n ϭ 21).
The diagnosis of all malignant tumors and 67 benign soft-tissue tumors was confirmed by histologic examination. The diagnosis of the remaining 40 benign soft-tissue tumors was made with the help of ancillary imaging investigations with clinical follow-up of a minimum of 6 months; 10 hemangiomas, 5 schwannomas, 5 inflammatory lesions, 4 lipomas, 4 hematomas, 4 fibromas, and 8 others.
201-Tl Scintigraphy
Thallium-201 scintigraphy was performed per institutional protocol: intravenous bolus of 74 MBq (2mCi) of 201-Tl was administered, and scintigraphic images were obtained using a gamma camera at 15 minutes (early imaging) and 2 hours (delayed imaging) after the injection. Interval change in 201-Tl uptake in the lesion was contrasted with the contralateral normal anatomic area or the area adjacent to the tumor. Early and delayed imaging obtained prior to 2003 were printed, and imported to a computer. From 2003, digital images were obtained that were exported directly to the computer. Images were analyzed using ImageJ software (National Institutes of Health, Bethesda, MD). Two equally sized regions of interest (ROI) were compared on each image ( Figure 1 ). The first ROI was focused on the lesion itself and the second ROI was placed on the contralateral side or the area adjacent to the tumor in a normal area to serve as a control. 13 When 201-Tl uptake was not detectable on the image, the ROI was placed on the area corresponding to images obtained by CT or MRI (Figs. 2, 3 ). For each ROI, the average counts per pixel were calculated using ImageJ software.
Excluding background activity, the tumor-to-background ratio (TBR) was calculated by dividing the average counts per pixel of ROI on the tumor area (T) by that of the background (BG);
The rate of change of TBR on early (TE) and delayed (TD) imaging was also calculated as:
Rate of change of TBR ϭ ͓͑TE Ϫ TD)/TE͔ ϫ 100.
Statistical Analysis
Statistical significance was ascertained by the Mann-Whitney's U test and the 2 test, using Stat View 5.0J statistical software (SAS Institute Inc, Cary, NC). P ϭ 0.05 was considered statistically significant.
RESULTS
There were 85 malignant soft-tissue tumors and 107 benign soft-tissue tumors ( Tables 1, 2 ). Of the malignant soft-tissue tumors, 63 were located in the lower extremity, 13 in the upper extremity, and 9 in the trunk. Of the 107 benign soft-tissue tumors, 54 were located in the lower extremity, 41 in the upper extremity, and 12 in the trunk. TBR for all malignant and benign soft-tissue tumors on early and delayed imaging was obtained.
Mean TBR on early imaging of all benign tumors was 22% Ϯ 42% ( Table 1) , and of all malignant tumors was 124% Ϯ 109% ( Table 2 ). Mean TBR on early imaging of malignant tumors was significantly higher than that of benign tumors (P Ͻ 0.0001). In addition, there was a statistically significant difference in mean TBR between malignant and benign tumors on delayed imaging (P Ͻ 0.0001). Mean rate of change of TBR on early and delayed imaging was 69% Ϯ 108% for all benign soft-tissue tumors, and 27% Ϯ 40% for all malignant tumors. Mean rate of reduction in isotope accumulation on delayed imaging was significantly higher in benign versus malignant soft-tissue tumors (P Ͻ 0.005).
A TBR cutoff of 20% on early imaging was found to be 82% sensitivity and 77% specificity; on delayed imaging, specificity increased to 84% (Table 3) . A TBR of 20% on both early and delayed imaging was a statistically significant indicator of malignancy (P Ͻ 0.0001). False-negative results (TBR of less than 20% on both early and delayed imaging) were found in 15 malignant tumors (11 well-differentiated liposarcomas, 3 myxoid liposarcomas, and 1 malignant peripheral nerve sheath tumor). False-positive results (TBR of Ͼ20% on early and delayed imaging) were found in 17 benign soft-tissue tumors (7 Giant cell tumor of tendon sheath, 4 pigmented villonodular synovitis, 3 inflammatory lesions, 2 desmoids, and 1 synovial osteochondromatosis), although not all benign tumors of these histologic subtypes were falsely positive. High accumulation of 201-Tl tracer in early imaging followed by marked reduc- Thallium-201 Scintigraphy tion (akin to rapid reduction) on delayed imaging occurred in 4 inflammatory lesions, 3 hemangiomata, and 1 schwannoma (Table 4 ).
DISCUSSION
Thallium-201 scintigraphy has been used in clinical oncology for estimating the presence and biologic activity of tumors, including those in bone and soft tissue. Since 201-Tl uptake is not only flow-dependent, but engages active transport mechanism, the 201-Tl accumulation may indicate tumor cell viability and metabolic activity. 14 -16 Early articles reported a high affinity for 201-Tl in musculoskeletal sarcomas. [17] [18] [19] High accumulation of 201-Tl on scintigraphy could be a positive indicator of malignancy in the evaluation of soft-tissue tumors.
In our study, mean TBR on both early and delayed 201-Tl scintigraphy was found to be significantly higher in malignant versus benign soft-tissue tumors, with an acceptable level of accuracy.
Our results also showed a predictable trend in false negativity. In our series, well-differentiated liposarcoma, a less aggressive tumor, most frequently had negative uptake, with a TBR of less than 3% on both early and delayed imaging. In 43% of patients with myxoid liposarcoma, 201-Tl uptake was also negative. Previous reports confirm our findings; 8, 11, 20 perhaps this could be attributed to the hypocellularity and large amount of intercellular matrix in liposarcomas. Twenty percent of malignant peripheral sheath tumors demonstrated negative thallium uptake in our series, a finding which was also seen by Terui et al 11 who reported a 44% false-negative rate of 201-Tl scintigraphy in neurogenic sarcoma. Histologically, 1 false-negative malignant peripheral nerve sheath tumor showed a marked myxoid change arising from neurofibromatosis, which may have led to decreased tracer accumulation. Previous published articles reported a low retention rate of 201-Tl on delayed imaging in benign tumors. 8, 21 In our study, benign soft-tissue tumors showed a significantly lower retention rate on delayed imaging (higher rate of change of TBR). Of the 25 falsely positive benign soft-tissue tumors on early imaging, 8 showed rapid washout of 201-Tl on delayed imaging, perhaps indicating viability of benign lesions. False positives were also seen in other studies, 11, 12 with persistently elevated 201-Tl uptake in histologically aggressive variants with high recurrence rates. Again, high accumulation of 201-Tl may be a marker for increased biologic activity or viability, especially on delayed imaging.
In our series, all hemangiomata with high tracer accumulation (TBR Ͼ20%) on early imaging showed a marked decrease (TBR Ͻ20%) on delayed imaging. Higuchi et al reported similar results in hemangiomata. 22 High accumulation on early imaging followed by rapid washout on delayed imaging is a distinctive feature of hemangiomata in other radiographic modalities (triple-phase CT, MRI, contrast ultrasound), and may be helpful in the diagnosis of hemangioma.
Positron emission tomography (PET) uses tissue metabolism of FDG, a glucose analog, in a similar model to that of 201-Tl scintigraphy. 8, 23 FDG PET can be used for discriminating between sarcomas and benign tumors, 24 -26 with a sensitivity between 83% and 93% and specificity between 81% and 91%, 27 similar to our results using 201-Tl scintigraphy. Both viable tumors and inflammatory tissue showed high accumulation on FDG PET; moreover, FDG PET cannot reliably differentiate between benign and lowgrade sarcoma. These findings limit the use of FDG PET in the management of soft-tissue tumors. Integrated PET/CT may be more suitable for anatomic and functional imaging of musculoskeletal tumors, although this requires additional investigation. PET imaging has only recently been covered by national health insurance in Japan and 201-Tl scintigraphy is less expensive than FDG PET.
In conclusions, mean TBR on both early and delayed 201-Tl scintigraphy was found to be significantly higher in malignant versus benign soft-tissue tumors, with an acceptable level of accuracy. A TBR of 20% on both early and delayed imaging was a statistically significant indicator of malignancy. False-negative results were found in 15 malignant tumors (14 low-grade liposarcoma variants), indicating tumors of low biologic activity. The 17 falsepositive results observed on delayed imaging may indicate histo-logic aggressiveness of benign tumors with high probability of recurrence rates. Again, high accumulation of 201-Tl may be a marker for increased biologic activity or viability. With the exception of low-grade liposarcomas and locally aggressive benign tumors, 201-Tl scintigraphy may be an effective diagnostic modality to differentiate malignant from benign soft-tissue tumors. Further studies are necessary to confirm our findings, especially with the evolution of newer 201-Tl modalities and integrated PET/CT. 
